Okay, let's start by understanding the user's query. They want a detailed explanation for an MCQ about the main concern in drug designing. The correct answer is missing, so I need to figure out what the correct answer is likely to be based on common pharmacology topics.

First, the core concept here is drug design principles. The main concerns in drug design typically include factors like drug-receptor interaction, pharmacokinetics, pharmacodynamics, toxicity, and selectivity. The question is asking for the primary concern, so I need to determine which of these is most critical.

In pharmacology, the main goal of drug design is often to ensure that the drug interacts specifically with its target (like a receptor or enzyme) to produce the desired therapeutic effect while minimizing side effects. This involves optimizing the drug's affinity and selectivity for the target. So, the correct answer is likely related to drug-receptor interactions or selectivity.

Now, looking at possible options (even though they're not provided), common distractors might include things like cost of production, ease of synthesis, or solubility. The correct answer should focus on the interaction between the drug and its target. For example, if the options are about selectivity, affinity, solubility, or metabolism, the correct one would be selectivity or affinity.

For the explanation, the core concept would be that drug design aims to optimize interactions with specific targets to maximize efficacy and minimize toxicity. The correct answer would be explained in terms of how selectivity for the target receptor reduces off-target effects. The wrong options would be incorrect because they address secondary concerns or are less critical in the initial design phase.

Clinical pearls might include mnemonics like "SELECTIVE DRUG DESIGN" or emphasizing that high selectivity reduces adverse effects. The final answer would be the option that refers to drug-receptor interaction selectivity or affinity.

**Core Concept**
In drug design, the primary focus is optimizing **drug-receptor interactions** to achieve therapeutic efficacy while minimizing toxicity. Key principles include **selectivity** (targeting specific receptors/enzymes), **affinity** (binding strength), and **efficacy** (maximal response). This ensures the drug acts precisely where needed without off-target effects.

**Why the Correct Answer is Right**
The correct answer would emphasize **selectivity** for the target receptor or enzyme. For example, if the answer is "Selectivity for the target receptor," this is because drugs must bind specifically to their intended molecular target (e.g., dopamine D2 receptors for antipsychotics) to avoid activating unintended pathways (e.g., histamine H1 receptors causing sedation). Selectivity is achieved through structural modifications to enhance binding affinity for the target while excluding off-target interactions.

**Why Each Wrong Option is Incorrect**
**Option A:** "High solubility" is incorrect. While solubility affects bioavailability, it is secondary to selectivity in prioritizing therapeutic action.
**Option B:** "Low cost of production" is incorrect. Cost is a commercial concern, not a primary pharmacological design principle.
**Option C:** "Ease of synthesis" is incorrect. Synthetic simplicity is practical but does not guarantee efficacy or safety.
**Option D:** "High molecular weight" is incorrect. Large molecules often face poor membrane permeability, limiting drug-like properties.

**Clinical Pearl / High-Yield Fact**
**"SELECT

✓ Correct Answer: C. Increasing number of interactions of drug with target protein